Exploiting the differential production of angiogenic factors within the tumor microenvironment in the design of a novel vascular-targeted gene therapy-based approach to the treatment of cancer
- 1 December 2002
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 54 (5) , 1473-1478
- https://doi.org/10.1016/s0360-3016(02)03921-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Current Progress in Suicide Gene Therapy for CancerWorld Journal of Surgery, 2002
- Enhancement of radiation therapy by the novel vascular targeting agent ZD6126International Journal of Radiation Oncology*Biology*Physics, 2002
- Adenoviral Gene TherapyThe Oncologist, 2002
- Cancer Gene Therapy: Scientific BasisAnnual Review of Medicine, 2002
- Targeting of High-Capacity Adenoviral VectorsHuman Gene Therapy, 2001
- Tissue-specific gene therapy directed to tumor angiogenesisGene Therapy, 2001
- Targeting tumour vasculature: the development of combretastatin A4The Lancet Oncology, 2001
- Molecular Adaptors for Vascular-Targeted Adenoviral Gene DeliveryHuman Gene Therapy, 2000
- Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancersGene Therapy, 2000
- A simplified system for generating recombinant adenovirusesProceedings of the National Academy of Sciences, 1998